Refills vs TMates: Price, Doctor Access, and Formulations Compared
Refills vs TMates is a price and supervision comparison. Quick verdict: Refills is the lower-cost flat option at $99/month for personalized compounded GLP-1, while TMates is $199/month with 24/7 U.S. doctor access and a clinician-focused model.
How Refills and TMates differ at a glance
This comparison focuses on five distinctive differences supported by the sources: price and flat-rate structure, clinician access and supervision, available formulations and drugs, regulatory and compounded medication notes, and shipping, cancellation, and membership terms. Both providers use compounded medications, which the sources note are not FDA-approved finished products.
1. Price and flat pricing model
Price is the clearest split. Refills advertises personalized compounded GLP-1 from $99/month (~$5/day) with flat pricing the same at every dosage and specific pricing examples such as semaglutide at $99/mo and tirzepatide at $159/mo. TMates advertises a flat $199/month, the same price at every dose with no step-up fees. The comparison is direct: Refills positions itself as a lower entry price, while TMates positions itself as a higher-cost flat program.
2. Clinician access and ongoing supervision
TMates emphasizes continuous physician availability: 24/7 access to U.S.-based doctors and virtual check-in appointments for ongoing oversight. Refills offers licensed clinician review after the intake quiz, clinician chats or prescription within 24 hours in many cases, and unlimited access to a patient care team and clinicians for questions at no extra cost. The difference is one of emphasis: TMates highlights 24/7 U.S.-based doctors, while Refills highlights on-demand clinician review and unlimited clinician consultations bundled into a monthly price.
3. Formulations and medications offered
Refills lists multiple options including semaglutide and tirzepatide and also notes a GIP plus GLP-1 dual agonist may be available. Refills states tirzepatide is priced at $159/mo in its examples. TMates centers on compounded semaglutide and highlights clinically dosed compounded semaglutide formulated in U.S. facilities; TMates mentions tirzepatide publicly but with limited detail and the site emphasizes semaglutide as its primary program. If choice of drug formulation matters, Refills documents both semaglutide and tirzepatide pricing details while TMates focuses on semaglutide with clinical dosing and domestic formulation.
4. Regulatory note and compounded medication status
Both sources include the same regulatory qualifier: compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Refills explicitly states compounded medications are highly regulated and compounding pharmacies are licensed and inspected, but reiterates the FDA has not evaluated those products. TMates likewise states its medication is compounded, not an FDA-approved finished product, while noting it uses the same active ingredient as branded options.
5. Shipping, membership, cancellation, and availability
Refills promotes free discreet shipping, express shipping options, availability in all 50 states, no monthly membership or app fees, month-to-month plans with the ability to cancel anytime and no cancellation fees. TMates advertises free shipping, cancel anytime, shipping to most or all states with availability based on medical eligibility, and a direct-pay flat model. Both note prescriptions are required and availability depends on medical eligibility or clinician review.
| Criteria | Refills | TMates |
|---|---|---|
| Starting price | $99/month (~$5/day) for GLP-1 | $199/month flat |
| Flat pricing at every dose | Yes, same price at every dosage | Yes, same price at every dose, no step-up fees |
| Clinician access | Licensed clinician review, chat or prescription within 24 hours; unlimited clinician access bundled | 24/7 access to U.S.-based doctors and virtual check-ins |
| Medications offered | Semaglutide, tirzepatide, GIP+GLP-1 dual agonist available | Compounded semaglutide clinically dosed; limited public detail on tirzepatide |
| Regulatory note | Compounded meds not FDA-approved or evaluated | Compounded meds not FDA-approved or evaluated |
| Shipping and cancellation | Free discreet shipping, express shipping, cancel anytime, no membership fees | Free shipping, cancel anytime, availability based on medical eligibility |
What matters most when choosing: price, supervision, or formulation
If price is the primary concern, Refills documents a clear lower starting price at $99/month and explicit examples for semaglutide and tirzepatide pricing. If continuous access to U.S.-based physicians and a clinician-first model is most important, TMates points to 24/7 doctor access and scheduled virtual check-ins. If you want explicit mention of tirzepatide pricing and multiple formulation options, Refills includes tirzepatide pricing detail and mentions GIP plus GLP-1 availability.
See TMates clinician-first program
Bottom line and how to choose
Refills vs TMates presents a tradeoff between cost and clinician availability. Refills is the lower-cost flat option with multiple documented formulations and month-to-month, no-membership terms. TMates is the higher-cost flat option focused on 24/7 U.S. doctor access and clinically dosed compounded semaglutide. Both use compounded medications that are not FDA-approved finished products and require a prescription and clinician review.
Choose Refills if you want the lowest advertised starting price, multiple formulation examples including tirzepatide pricing, free discreet shipping, and month-to-month, no-membership terms.
Choose TMates if you prioritize 24/7 access to U.S.-based doctors and a clinician-focused, clinically dosed semaglutide program at a flat $199/month price.